Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Star Scientific Inc. Stories

2011-09-27 09:30:00

GLEN ALLEN, Va., Sept. 27, 2011 /PRNewswire/ -- Rock Creek Pharmaceuticals, a subsidiary of Star Scientific, Inc. (NASDAQ: CIGX), has announced the expansion of shipping options for purchases of its dietary supplement, Anatabloc(TM). As the company indicated in an August 30 release on the product launch, Anatabloc(TM) contains the dietary ingredient anatabine citrate. Anatabine is an alkaloid that is found in a variety of plants in the Solinacea family, including the tobacco plant as well...

2011-09-20 08:30:00

GLEN ALLEN, Va., Sept. 20, 2011 /PRNewswire/ -- Rock Creek Pharmaceuticals, a subsidiary of Star Scientific, Inc. (NASDAQ: CIGX), announced that on September 19, 2011 a utility patent application was filed with the Patent and Trademark Office ("PTO"). This utility patent application is based on several previously-filed provisional applications, and it is directed to various products containing anatabine and the administration of anatabine to reduce inflammation. Anatabine has the potential...

2011-08-30 12:00:00

GLEN ALLEN, Va., Aug. 30, 2011 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) has announced that the company is pleased to initiate the launch today of Anatabloc(TM), a dietary supplement that is designed to support the immune system in maintaining healthy levels of inflammation. Anatabloc(TM), developed by the company's Rock Creek Pharmaceuticals subsidiary, is being launched via a dedicated website (www.anatabloc.com) where the product can be purchased. The product also can be...

2011-08-26 12:30:00

GLEN ALLEN, Va., Aug. 26, 2011 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) issued the following statement regarding the decision issued today by the Federal Circuit Court of Appeals on the company's appeal of the jury verdict in the trial of Star's patent infringement lawsuit against RJ Reynolds Tobacco Company: (Logo: http://photos.prnewswire.com/prnh/20090317/STARSCIENTIFICLOGO) "We are gratified that the Federal Circuit Court of Appeals has affirmed the validity of the...

2011-08-09 09:00:00

GLEN ALLEN, Va., Aug. 9, 2011 /PRNewswire/ -- Star Scientific, Inc (NASDAQ: CIGX) filed its second-quarter 2011 financial report on Form 10-Q today with the Securities and Exchange Commission (SEC). The company reported net sales totaling $262 thousand for the three months ended June 30, 2011 and $418 thousand for the six months ended June 30, 2011. Second quarter 2011 net sales increased 68% from the first quarter 2011 sales of $156 thousand. This increase was due in large part to...

2011-05-11 08:30:00

GLEN ALLEN, Va., May 11, 2011 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) filed its report on first-quarter 2011 yesterday with the Securities and Exchange Commission (SEC). The company reported first-quarter net sales totaling $156 thousand compared with $149 thousand for the same quarter in 2010. Sales of CigRx®, the dietary supplement developed by the Rock Creek Pharmaceuticals subsidiary and in test market since August 2010, contributed 29.5% of first-quarter...

2011-04-05 11:18:00

GLEN ALLEN, Va., April 5, 2011 /PRNewswire/ -- Star Scientific, Inc (NASDAQ: CIGX) has issued the following statement: It has been brought to our attention that a headline has been running via the Bloomberg News outlet that states the company "failed to meet NASDAQ continued listing requirements". We have confirmed with Nasdaq that there is no listing deficiency. This headline is completely incorrect, and the company has serious concerns about its source. Star is in the process of...

2011-03-23 18:15:00

WASHINGTON, March 23, 2011 /PRNewswire-USNewswire/ -- The following is a statement of Matthew L. Myers, President, Campaign for Tobacco-Free Kids: (Logo: http://photos.prnewswire.com/prnh/20080918/CFTFKLOGO) It is inexplicable and troubling that the U.S. Food and Drug Administration has told Star Scientific Inc. that the company's Ariva-BDL and Stonewall-BDL smokeless tobacco products are not currently subject to FDA regulation. The FDA has created a loophole where no loophole existed...

2011-03-23 08:30:00

GLEN ALLEN, Va., March 23, 2011 /PRNewswire/ -- Star Scientific, Inc. (Nasdaq: CIGX) announced that the company has received notices from the Food and Drug Administration (FDA) regarding its pending ARIVA-BDL(TM) and STONEWALL-BDL(TM) modified risk tobacco product applications. The notices from Lawrence Deyton, MD, MSPH, Director of the FDA Center for Tobacco Products (CTP), state, in part, "Not all tobacco products are currently subject to Chapter IX of the FDCA [Federal Food Drug &...

2011-03-17 17:06:00

In the news release, Richard L. Sharp, Former Board Chair of Circuit City, Carmax, Joins Star Scientific Board, issued 17-Mar-2011 by Star Scientific, Inc. over PR Newswire, we are advised by the company that the release contained some incorrect information, as originally issued inadvertently. The complete, corrected release follows: Richard L. Sharp, Former Board Chair of Circuit City, CarMax, Joins Star Scientific Board GLEN ALLEN, Va., March 17, 2011 /PRNewswire/ -- Star Scientific,...